Crossmark

A 24 month follow-up of refractory macular holes treated with an autologous transplantation of internal limiting membrane versus retina expansion technique

Crossref DOI link: https://doi.org/10.1186/s40942-021-00329-1

Published Online: 2021-10-02

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alezzandrini, Arturo

Dorrego, Camila I.

Cibrán, María Victoria

Cortina-Revelli, Valentina

Rocco, Franco D.

Zas, Marcelo

Wu, Lihteh https://orcid.org/0000-0002-3387-7058
License Information

Text and Data Mining valid from 2021-10-02

Version of Record valid from 2021-10-02
More Information

Article History

Received: 19 April 2021

Accepted: 16 September 2021

First Online: 2 October 2021

Declarations

:

: The study was approved by the IRB of the Instituto de Alta Complejidad Oftalmos, Buenos Aires, Argentina.

: Not applicable.

: CID, MVC, VCR and FDR declare that they have competing interests.AA has participated in advisory boards for Roche, Alcon, Bayer and Novartis.MZ has received speaker fees from Alcon, Bayer, Abbvie, Poen and Novo Nordisk.LW has received speaker fees from Bayer and Quantel Medical

Document is current

Any future updates will be listed below